HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,348,765 | -16.5% | 61,486 | -21.1% | 0.01% | -18.2% |
Q2 2023 | $2,811,837 | +95.3% | 77,955 | +106.8% | 0.01% | +83.3% |
Q1 2023 | $1,439,457 | -13.7% | 37,692 | +28.5% | 0.01% | -14.3% |
Q4 2022 | $1,668,649 | +65.9% | 29,326 | +15.2% | 0.01% | +40.0% |
Q3 2022 | $1,006,000 | +947.9% | 25,450 | +1067.4% | 0.01% | – |
Q2 2022 | $96,000 | +77.8% | 2,180 | +62.1% | 0.00% | – |
Q1 2022 | $54,000 | -5.3% | 1,345 | -4.3% | 0.00% | – |
Q4 2021 | $57,000 | +3.6% | 1,406 | +3.8% | 0.00% | – |
Q3 2021 | $55,000 | -1.8% | 1,355 | +9.7% | 0.00% | – |
Q2 2021 | $56,000 | +9.8% | 1,235 | 0.0% | 0.00% | – |
Q1 2021 | $51,000 | +27.5% | 1,235 | +32.8% | 0.00% | – |
Q4 2020 | $40,000 | – | 930 | +6100.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 15 | -92.5% | 0.00% | – |
Q4 2014 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |